A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens
Kristine Broglio(Berry & Associates (United States)), Scott Berry(Queen's University), Dane Van Den Akker(The Lundquist Institute), Roger Lewis(University of California, Los Angeles), Michelle A. Detry(Berry & Associates (United States)), Melanie Quintana(Berry & Associates (United States)), Eric S. Daar(UCLA Medical Center), Trong Kim Le(Bristol-Myers Squibb (United States)), Yong Yuan(Kunming Medical University), Anupama Kalsekar(Bristol-Myers Squibb (United States)), Brad Spellberg(University of Southern California)
Cited by 4
Related Papers
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
|New England Journal of Medicine|2002|1.1k
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
|New England Journal of Medicine|2013|980